[Treatment effects of parent management training for ADHD].
OBJECTIVE
The study investigated the efficacy of a programme of parent management training in groups for the parents of ADHD children that is based on a cognitive behavioural concept.


METHODS
The parents of 16 ADHD children participated in group training over a ten-week period. Children were medicated with methylphenidate and received consultations. 17 other ADHD children (control group) benefited only from medication with methylphenidate plus consultation; however, their parents did not participate in any group training. In both groups, assessment was done by means of parent questionnaires: in the experimental group to assess the core symptoms of ADHD, homework problems and global problems that occur in families with ADHD; in the control group to assess only the core symptoms of ADHD.


RESULTS
The training significantly reduced core symptoms of ADHD, homework problems and global problematic situations in the experimental group. In comparison to the control group, the core symptoms of ADHD decreased more strongly in the experimental group. This effect failed to reach the significance level of p < 0.05 (Mann-Whitney U-test). However, the verification with the linear model showed a significant difference between the two groups on the factor "hyperactivity index".


CONCLUSIONS
Parent management training in groups was a useful adjunct in the treatment of ADHD children.
Salbach
Harriet
H
Charité, Universitätsmedizin Berlin, Klinik für Psychiatrie, Psychosomatik und Psychotherapie des Kindes- und Jugendalters, Berlin. harriet.salbach@charite.de
Lenz
Klaus
K
Huss
Michael
M
Vogel
Regina
R
Felsing
Doris
D
Lehmkuhl
Ulrike
U
D001289:Attention Deficit Disorder with Hyperactivity / Q000628:therapy*; D000697:Central Nervous System Stimulants / Q000627:therapeutic use; D002648:Child; D002653:Child Behavior Disorders / Q000628:therapy; D015928:Cognitive Behavioral Therapy / Q000193:education; D003131:Combined Modality Therapy; D004493:Education; D005260:Female; D006126:Group Processes; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000627:therapeutic use; D010552:Personality Assessment; D010555:Personality Inventory; D012017:Referral and Consultation; D012918:Social Alienation; D016896:Treatment Outcome
D000697:Central Nervous System Stimulants; D008774:Methylphenidate